Real-world Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-17 Inhibitors: A 16-week Multicenter Retrospective Review

被引：0
|
作者：
Sood, Siddhartha [1 ]
Rimke, Alexander [2 ]
Rankin, Brian [3 ]
Abduelmula, Abrahim [4 ]
Georgakopoulos, Jorge [4 ]
Maliyar, Khalad [4 ]
Bagit, Ahmed [1 ]
Leung, Fernejoy [5 ]
Devani, Alim [5 ]
Vender, Ronald [6 ]
Yeung, Jensen [4 ]
Prajapati, Vimal [3 ]
机构：
[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada
[2] Dermatol Res Inst, Calgary, AB, Canada
[3] Univ Calgary, Div Dermatol, Dept Med, Calgary, AB, Canada
[4] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON, Canada
[5] Skin Hlth & Wellness Ctr, Calgary, AB, Canada
[6] McMaster Univ, Div Dermatol, Dept Med, Hamilton, ON, Canada
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0594
引用
收藏
页码：1216 / 1217
页数：2
相关论文
共 50 条
  • [31] REAL-WORLD EFFECTIVENESS AND SAFETY OF RISANKIZUMAB IN ADULT PATIENTS WITH PLAQUE PSORIASIS: A 1-YEAR INTERNATIONAL MULTICENTER RETROSPECTIVE COHORT STUDY
    Bagit, Ahmed
    Maliyar, Khalad
    Mansour, Mark
    Georgakopoulos, Jorge R.
    Rankin, Brian
    Lytvyn, Yuliya
    Zaaroura, Hiba
    Park, Miss Ye-Jean
    Wang, Emilie
    Mufti, Asfandyar
    Torres, Tiago
    Le, Ana M.
    Vender, Ronald
    Prajapati, Vimal H.
    Yeung, Jensen
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [32] Interleukin-23 versus Interleukin-17 Inhibitors in Preventing Incidental Psoriatic Arthritis in Patients with Psoriasis: A Real-World Comparison From the TriNetX US Collaborative Network
    Yu, Sebastian
    Huo, An-Ping
    Wang, Yu-Hsun
    Wei, James Cheng-Chung
    BIODRUGS, 2025, 39 (02) : 297 - 306
  • [33] Interim analysis of a real-world retrospective multicenter study: Evaluation of effectiveness of secukinumab in adult patients with moderate-to-severe plaque psoriasis in China
    Liu, N.
    Xiao, X.
    Pan, R.
    Li, W.
    Yang, B.
    Shi, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S69 - S69
  • [34] Risankizumab in obese patients with moderate-to-severe plaque psoriasis: a 104-week, real-world, retrospective study
    Rompoti, Natalia
    Koumprentziotis, Ioannis-Alexios
    Stefanaki, Irene
    Vavouli, Charitomeni
    Papoutsaki, Marina
    Politou, Maria
    Panagakis, Pantelis
    Befon, Angeliki
    Kousta, Fiori
    Lazou, Eleni
    Chasapi, Vasiliki
    Stratigos, Alexander
    Nicolaidou, Electra
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (09)
  • [35] Real-world experience ofbimekizumab for adult patients withplaque psoriasis: A 52-weekmulticenter retrospective study
    Sood, Siddhartha
    Rankin, Brian D.
    Abduelmula, Abrahim
    Georgakopoulos, Jorge R.
    Maliyar, Khalad
    Bagit, Ahmed
    Leung, Fernejoy
    Stark, Lauren A.
    Devani, Alim R.
    Vender, Ronald
    Yeung, Jensen
    Prajapati, Vimal H.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (05) : 936 - 939
  • [36] P96 Effectiveness and safety of bimekizumab for adult patients with plaque psoriasis: an interim analysis of 2-year data from a real-world, multicentre, retrospective study
    Sood, Siddhartha
    Rimke, Alexander
    Rankin, Brian
    Abduelmula, Abrahim
    Georgakopoulos, Jorge
    Maliyar, Khalad
    Bagit, Ahmed
    Leung, Fernejoy
    Devani, Alim
    Vender, Ronald
    Yeung, Jensen
    Prajapati, Vimal
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [37] A 60-week real-world experience with guselkumab in patients with moderate-to-severe plaque psoriasis including patients with malignancy: A retrospective study from Ontario, Canada
    Al-Rabai, Manal
    Al-Ghanemi, Lujain
    Steriopoulos, Julia
    Saleem, Ahmad
    Abu-Hilal, Mohannad
    JOURNAL OF DERMATOLOGY & DERMATOLOGIC SURGERY-JDDS, 2023, 27 (02): : 90 - 92
  • [38] Real-World Clinical Experience With Apremilast in a Large US Retrospective Cohort Study of Patients With Moderate to Severe Plaque Psoriasis
    Armstrong, April
    Levi, Eugenia
    JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (12) : 1240 - 1245
  • [39] Real-world risk of new onset inflammatory bowel disease among psoriasis patients exposed to interleukin 17 inhibitors
    Wright, S.
    Alloo, A.
    Strunk, A.
    Garg, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S62 - S62
  • [40] Real-world risk of new-onset inflammatory bowel disease among patients with psoriasis exposed to interleukin 17 inhibitors
    Wright, Shari
    Alloo, Allireza
    Strunk, Andrew
    Garg, Amit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (02) : 382 - 387
12345